AG
MNTA

Advisor Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Advisor Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,018
Closed -$27K – 5335
2018
Q3 		$27K Buy
1,018
+503
+98% +$13.6K ﹤0.01% 3707
2018
Q2 		$10K Sell
515
-7
-1% -$150 ﹤0.01% 4094
2018
Q1 		$10K Buy
522
+43
+9% +$717 ﹤0.01% 4109
2017
Q4 		$7K Buy
479
+271
+130% +$3.66K ﹤0.01% 4303
2017
Q3 		$4K Buy
208
+70
+51% +$1.17K ﹤0.01% 4387
2017
Q2 		$2K Sell
138
-37
-21% -$563 ﹤0.01% 4561
2017
Q1 		$2K Sell
175
-112
-39% -$1.75K ﹤0.01% 4448
2016
Q4 		$4K Sell
287
-51
-15% -$674 ﹤0.01% 4063
2016
Q3 		$4K Buy
338
+150
+80% +$1.76K ﹤0.01% 4023
2016
Q2 		$2K Buy
+188
New +$1.94K ﹤0.01% 4145

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Advisor Group's MNTA Position: Q4 2018 in Review

Advisor Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2018, closing a stake of 1,018 shares — an estimated $27K sold.

Advisor Group first reported a position in MNTA in Q2 2016 and held it in 10 quarters. The position peaked at $27K in Q3 2018. 158 funds tracked by Wall St. Rank hold MNTA as of Q4 2018.

  • Advisor Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Advisor Group sold 1,018 Momenta Pharmaceuticals, Inc. shares in Q4 2018, an estimated $27K.
  • Advisor Group first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 10 quarters.
  • Advisor Group's Momenta Pharmaceuticals, Inc. position peaked at $27K in Q3 2018.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2018.

Based on Advisor Group's 13F filing for Q4 2018, filed 11 Feb 2019.